230 related articles for article (PubMed ID: 35167781)
21. Patient Adherence to Lung CT Screening Reporting & Data System-Recommended Screening Intervals in the United States: A Systematic Review and Meta-Analysis.
Lin Y; Fu M; Ding R; Inoue K; Jeon CY; Hsu W; Aberle DR; Prosper AE
J Thorac Oncol; 2022 Jan; 17(1):38-55. PubMed ID: 34624528
[TBL] [Abstract][Full Text] [Related]
22. Racial Disparities in Lung Cancer Screening Among Veterans, 2013 to 2021.
Navuluri N; Morrison S; Green CL; Woolson SL; Riley IL; Cox CE; Zullig LL; Shofer S
JAMA Netw Open; 2023 Jun; 6(6):e2318795. PubMed ID: 37326987
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study.
Silvestri GA; Goldman L; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Tanner NT; Fedewa S
Ann Intern Med; 2022 Nov; 175(11):1501-1505. PubMed ID: 36215712
[TBL] [Abstract][Full Text] [Related]
24. An Evaluation of Annual Adherence to Lung Cancer Screening in a Large National Cohort.
Smith HB; Schneider E; Tanner NT
Am J Prev Med; 2022 Aug; 63(2):e59-e64. PubMed ID: 35365394
[TBL] [Abstract][Full Text] [Related]
25. Characterizing Lung-RADS category 4 lesions in a university lung cancer screening program.
Kocher Wulfeck M; Plesner S; Herndon JE; Christensen JD; Patz EF
Lung Cancer; 2023 Dec; 186():107420. PubMed ID: 37956610
[TBL] [Abstract][Full Text] [Related]
26. Factors Affecting Patient Adherence to Lung Cancer Screening.
Bellinger C; Foley K; Genese F; Lampkin A; Kuperberg S
South Med J; 2020 Nov; 113(11):564-567. PubMed ID: 33140110
[TBL] [Abstract][Full Text] [Related]
27. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
[TBL] [Abstract][Full Text] [Related]
28. Racial Disparities in Lung Cancer Screening: An Exploratory Investigation.
Japuntich SJ; Krieger NH; Salvas AL; Carey MP
J Natl Med Assoc; 2018 Oct; 110(5):424-427. PubMed ID: 30129479
[TBL] [Abstract][Full Text] [Related]
29. Timely adherence to follow-up after high-risk lung cancer screenings.
Kee D; Sigel KM; Wisnivesky JP; Kale MS
J Med Screen; 2023 Sep; 30(3):150-155. PubMed ID: 36916158
[TBL] [Abstract][Full Text] [Related]
30. Individual- and neighborhood-level characteristics of lung cancer screening participants undergoing telemedicine shared decision making.
Shusted CS; Juon HS; Ruane B; Till B; Zeigler-Johnson C; McIntire RK; Grenda T; Okusanya O; Evans NR; Kane GC; Barta JA
BMC Health Serv Res; 2023 Oct; 23(1):1179. PubMed ID: 37899430
[TBL] [Abstract][Full Text] [Related]
31. Likelihood of Lung Cancer Screening by Poor Health Status and Race and Ethnicity in US Adults, 2017 to 2020.
Rustagi AS; Byers AL; Keyhani S
JAMA Netw Open; 2022 Mar; 5(3):e225318. PubMed ID: 35357450
[TBL] [Abstract][Full Text] [Related]
32. Racial and Ethnic Disparities in Lung Cancer Screening Eligibility.
Narayan AK; Chowdhry DN; Fintelmann FJ; Little BP; Shepard JO; Flores EJ
Radiology; 2021 Dec; 301(3):712-720. PubMed ID: 34546133
[TBL] [Abstract][Full Text] [Related]
33. Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice.
Mendoza DP; Petranovic M; Som A; Wu MY; Park EY; Zhang EW; Archer JM; McDermott S; Khandekar M; Lanuti M; Gainor JF; Lennes IT; Shepard JO; Digumarthy SR
AJR Am J Roentgenol; 2022 Jul; 219(1):55-65. PubMed ID: 35080453
[No Abstract] [Full Text] [Related]
34. Perceptions and Utilization of Lung Cancer Screening Among Primary Care Physicians.
Raz DJ; Wu GX; Consunji M; Nelson R; Sun C; Erhunmwunsee L; Ferrell B; Sun V; Kim JY
J Thorac Oncol; 2016 Nov; 11(11):1856-1862. PubMed ID: 27346412
[TBL] [Abstract][Full Text] [Related]
35. Lung Cancer Screening in Clinical Practice: A 5-Year Review of Frequency and Predictors of Lung Cancer in the Screened Population.
Lafata KJ; Read C; Tong BC; Akinyemiju T; Wang C; Cerullo M; Tailor TD
J Am Coll Radiol; 2024 May; 21(5):767-777. PubMed ID: 37952807
[TBL] [Abstract][Full Text] [Related]
36. Adherence to annual lung cancer screening with low-dose CT scan in a diverse population.
Erkmen CP; Dako F; Moore R; Dass C; Weiner MG; Kaiser LR; Ma GX
Cancer Causes Control; 2021 Mar; 32(3):291-298. PubMed ID: 33394208
[TBL] [Abstract][Full Text] [Related]
37. Use of Diagnostic CT and Patient Retention in a Lung Cancer Screening Program.
Byrne SC; Hammer MM
J Am Coll Radiol; 2022 Jan; 19(1 Pt A):47-52. PubMed ID: 34752759
[TBL] [Abstract][Full Text] [Related]
38. Promoting lung cancer screening of high-risk patients by primary care providers.
Colamonici M; Khouzam N; Dell C; Auge-Bronersky K; Pacheco E; Rubinstein I; Recht B
Cancer; 2023 Nov; 129(22):3574-3581. PubMed ID: 37449669
[TBL] [Abstract][Full Text] [Related]
39. Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance.
Carroll NM; Burnett-Hartman AN; Joyce CA; Kinnard W; Harker EJ; Hall V; Steiner JS; Blum-Barnett E; Ritzwoller DP
J Gen Intern Med; 2020 Apr; 35(4):1143-1152. PubMed ID: 31974902
[TBL] [Abstract][Full Text] [Related]
40. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
Fintelmann FJ; Bernheim A; Digumarthy SR; Lennes IT; Kalra MK; Gilman MD; Sharma A; Flores EJ; Muse VV; Shepard JA
Radiographics; 2015; 35(7):1893-908. PubMed ID: 26495797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
